Recent studies in the United Kingdom have shown that dexamethasone reduces the risk of death in patients with COVID-19 who need oxygen support, the World Health Organization Country office in Azerbaijan told APA.
According to the WHO office,dexamethasone COVID-19 should not be used in patients who do not need oxygen support.
The WHO Country Office in Azerbaijan warns that there is no evidence of use for this purpose and that the drug has serious side effects if not used properly.